��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Quantifying Clinical Predictors of Optimal Response to Natalizumab in Multiple Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 207

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Sonia Batista, MD (Hospital Universidade Coimbra)	Dr. Batista has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Novartis, Roche, Sanofi Genzyme, Merck. Dr. Batista has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Novartis, Roche, Sanofi Genzyme, Merck.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Livia D. Sousa, MD (Centro Hospitalar E Universitario De Coimbra)	Dr. Sousa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer,Merck,Novartis,Biogen,Saniofi,Roche.